Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Ophthalmic Surg Lasers Imaging Retina ; 54(6): 330-336, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-37352397

RESUMO

OBJECTIVES: To describe multimodal imaging findings of vitamin A deficiency retinopathy. METHODS: A retrospective study of patients with serum retinol < 0.3 mg/L. Fundus color photos, spectral domain-optical coherence tomography (SD-OCT), and fundus autofluorescence (FAF) were reviewed and, when available, electrophysiological tests were analyzed. RESULTS: Forty-five eyes (63.9 ± 15.7 years) were included. Ultra-widefield fundus photography showed drusen-like deposits (53.3%) and macular retinal pigment epithelium (RPE) mottling (40%). The deposits were hypoautofluorescent, and a perifoveal hyperautofluorescent ring was present in 8.9%. By SD-OCT, the ellipsoid zone had an irregular appearance (100%) and conical deposits anterior to the RPE (33.3%). Electroretinogram (ERG) (66.7%) showed a decrease in b-wave in the scotopic registers, and microperimetry (4.4%) showed decreased foveal sensitivity. After vitamin A supplementation, SD-OCT and FAF showed resolution of all findings. Forty percent of eyes had restoration of the scotopic registers in ERG and improved macular sensitivity by microperimetry (4.4%). CONCLUSIONS: Vitamin A deficiency causes a mild cone dysfunction in addition to the more severe absent rod response. [Ophthalmic Surg Lasers Imaging Retina 2023;54:330-336.].


Assuntos
Doenças Retinianas , Deficiência de Vitamina A , Humanos , Deficiência de Vitamina A/complicações , Deficiência de Vitamina A/diagnóstico , Estudos Retrospectivos , Retina , Transtornos da Visão , Tomografia de Coerência Óptica , Imagem Multimodal , Angiofluoresceinografia
2.
Ocul Surf ; 18(4): 871-892, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32927081

RESUMO

Meibomian gland dysfunction (MGD) can be considered the leading cause of dry eye disease (DED) and one of the most common ophthalmic disorders found in clinical practice. The growing body of literature provides a substantial amount of information on this condition, but more efforts are needed to better interpret research data and to properly apply them to daily clinical practice., In this article, we reviewed the most recent publications on MGD diagnosis and management, focusing on the highest available level of evidence, provided by well-designed and well-reported studies on humans., Latest evidences on MGD diagnosis are mainly focused on imaging techniques, including meibography, optical coherence tomography (OCT), and in vivo confocal microscopy. Meibographic parameters, such as drop-out and glands' distortion, show great diagnostic accuracy, which accounts for their widespread use in clinical practice and research., Recent randomized controlled clinical trials on MGD treatment provided data on the role of antibiotics, steroids, essential fatty acids, intraductal meibomian gland probing, electronic heating devices and intense pulsed light therapy.


Assuntos
Disfunção da Glândula Tarsal , Síndromes do Olho Seco/diagnóstico , Síndromes do Olho Seco/terapia , Doenças Palpebrais/diagnóstico , Doenças Palpebrais/terapia , Humanos , Glândulas Tarsais , Tomografia de Coerência Óptica
3.
Int Ophthalmol ; 35(3): 319-23, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24752646

RESUMO

The purpose of the study was to evaluate the efficacy and safety of wet chamber warming goggles (Blephasteam(®)) in patients with meibomian gland dysfunction (MGD) unresponsive to warm compress treatment. We consecutively enrolled 50 adult patients with low-delivery, non-cicatricial, MGD, and we instructed them to apply warm compresses twice a day for 10 min for 3 weeks and to use Blephasteam(®) (Laboratoires Thea, Clermont-Ferrand, France) twice a day for 10 min for the following 3 weeks. We considered "not-responders" to warm compress treatment the patients who showed no clinically significant Ocular Surface Disease Index (OSDI) improvement after the first 3 weeks. Clinical and in vivo confocal outcome measures were assessed in the worst eye (lower BUT) at baseline, after 3 weeks, and after 6 weeks. Eighteen/50 patients were not-responders to warm compress treatment. These patients, after 3 weeks of treatment with Blephasteam(®), showed significant improvement of OSDI score (36.4 ± 15.8 vs 20.2 ± 12.4; P < 0.05, paired samples t test), increased BUT (3.4 ± 1.6 vs 7.6 ± 2.7; P < 0.05), and decreased acinar diameter and area (98.4 ± 18.6 vs 64.5 ± 14.4 and 8,037 ± 1,411 vs 5,532 ± 1,172, respectively; P < 0.05). Neither warm compresses nor Blephasteam(®) determined adverse responses. In conclusion, eyelid warming is the mainstay of the clinical treatment of MGD and its poor results may be often due to lack of compliance and standardization. Blephasteam(®) wet chamber warming goggles are a promising alternative to classical warm compress treatment, potentially able to improve the effectiveness of the "warming approach."


Assuntos
Bandagens , Síndromes do Olho Seco/terapia , Doenças Palpebrais/terapia , Hipertermia Induzida/métodos , Glândulas Tarsais , Adulto , Idoso , Síndromes do Olho Seco/patologia , Síndromes do Olho Seco/fisiopatologia , Dispositivos de Proteção dos Olhos , Doenças Palpebrais/patologia , Doenças Palpebrais/fisiopatologia , Feminino , Temperatura Alta/uso terapêutico , Humanos , Hipertermia Induzida/instrumentação , Masculino , Glândulas Tarsais/fisiopatologia , Microscopia Confocal , Pessoa de Meia-Idade , Lágrimas/fisiologia
4.
ScientificWorldJournal ; 2012: 481584, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22654614

RESUMO

PURPOSE: We describe in our study a modified standard enucleation, using sclera harvested from the enucleated eye to cover the prosthesis in order to insert a large porous implant and to reduce postoperative complication rates in a phthisis globe. METHODS: We perform initially a standard enucleation. The porous implant (Bioceramic) is then covered only partially by the patient's sclera. The implant is inserted in the posterior Tenon's space with the scleral covering looking at front. All patients were followed at least for twelve months (average followup 16 months). RESULTS: We performed nineteen primary procedures (19 patients, 19 eyes, x M; x F) and secondary, to fill the orbital cavity in patients already operated by standard evisceration (7 patients, 7 eyes). There were no cases of implant extrusion. The orbital volume was well reintegrated. CONCLUSION: Our procedure was safe and effective. All patients had a good cosmetic result after final prosthetic fitting and we also achieved good prothesis mobility.


Assuntos
Óxido de Alumínio/química , Enucleação Ocular/métodos , Implantes Orbitários , Esclera , Enucleação Ocular/efeitos adversos , Evisceração do Olho/efeitos adversos , Evisceração do Olho/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA